Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analytic Validation of the Optina Retinal Deep Phenotyping.TM (RDP) Platform

NCT06057493 is registered in ClinicalTrials.gov with Optina Diagnostics Inc. as lead sponsor.

NCT NCT06057493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06057493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analytic Validation of the Optina Retinal Deep Phenotyping.TM (RDP) Platform
Lead sponsor
Optina Diagnostics Inc.
Phase
Observational
Overall status
Completed
Start date
September 19, 2023
Completion date
February 6, 2024
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy